News
£1.2m grant support for 52 North Health collaboration with UnifAI, NHS, Macmillan and UK Sepsis Trust
The grant will enable 52 North Health’s NeutroCheck® solution to be expanded and taken into clinical trials
NeutroCheck aims to provide early identification of patients at risk of a potentially fatal side-effect of chemotherapy treatment, in order to give patients peace of mind and to help save lives
The funds, stemming from Innovate UK’s Smart Grant programme,
follow a smaller award made to 52 North Health in January 2020,
highlighting the progress that UK businesses can make through
government-funded innovation programmes
The 21-month collaboration will be between med-tech company 52 North Health, Macmillan Cancer Support, UK Sepsis Trust, UnifAI Technology and Cambridge University Hospitals
NeutroCheck aims to provide early identification of patients at risk of a potentially fatal side-effect of chemotherapy treatment, in order to give patients peace of mind and to help save lives
The funds, stemming from Innovate UK’s Smart Grant programme,
follow a smaller award made to 52 North Health in January 2020,
highlighting the progress that UK businesses can make through
government-funded innovation programmes
The 21-month collaboration will be between med-tech company 52 North Health, Macmillan Cancer Support, UK Sepsis Trust, UnifAI Technology and Cambridge University Hospitals
NIHR Awards
NIHR Awards 52 North £40k to Boost Patient-Centricity
CEO, Umaima Ahmad, featured in MT 35 Women under 35.
Our CEO, Umaima Ahmad, has been listed on Management Today's 35 Under 35 Women in Business for 2022.
Dr Ama Frimpong recognised as one of the top 50 Women in Engineering in The Guardian.
Dr Ama Frimpong, 52 North's Head of Product Development, recognised as one of the top 50 Women in Engineering in The Guardian.
Killer 50 List
Named in the Business Weekly newspaper's Killler 50 list of Ones2Watch.
Innovate UK KTP Award
£200k Innovate UK KTP award to support our collaboration with the Department of Chemistry to develop new diagnostic tests.
MedTech Innovator 2022
52 North Health selected for the world's largest MedTech accelerator programme, MedTech Innovator, in the 2022 cohort.
52 North wins Tech for Good Award
52 North raises £1m in first investment round
52 North awarded $1.4m from SBRI to bring NeutroCheck device to patients
52 North selected for BIOME UK HealthHub 21 accelerator
52 North wins SBRI Healthcare award
52 North selected as semi-finalist in Harvard President's Innovation Challenge
NeutroCheck featured in BBC News
52 North receives £125k MedTech Accelerator Award
52 North awarded Innovate UK grant